CStone Pharmaceuticals — Capital/Financing Update 2016

Jul 26, 2016

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [63 x 61] intentionally omitted <==

兗州煤業股份有限公司

YANZHOU COAL MINING COMPANY LIMITED

(A joint stock limited company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 1171)

SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION ESTABLISHMENT OF JOINT VENTURE

Reference is made to the announcement of Yanzhou Coal Mining Company Limited (the " Company ") dated 22 July 2016 in relation to the establishment of joint venture (the " Announcement "). Unless otherwise defined, capitalized terms used in this announcement shall have the same meanings as defined in the Announcement.

The Company wishes to supplement the information on the distribution of profits of the Joint Venture in the Announcement as follows:

The profits of the Joint Venture shall be distributed according to the following priority:

(1) firstly to Great Wall Securities, up to its expected annualized rate of return of 6.1% of its contribution amount;

(2) secondly to the Company, up to its expected annualized rate of return of 6.1% of its contribution amount; and

(3) the remaining balance to Duanxin Investment.

By order of the board of directors Yanzhou Coal Mining Company Limited Li Xiyong Chairman of the Board

1

Zoucheng, Shandong Province, the PRC 26 July 2016

As at the date of this announcement, the Directors are Mr. Li Xiyong, Mr. Li Wei, Mr. Wu Xiangqian, Mr. Wu Yuxiang, Mr. Zhao Qingchun, Mr. Guo Dechun and Mr. Guo Jun, and the independent non-executive Directors are Mr. Wang Li Jie, Mr. Jia Shaohua, Mr. Wang Xiaojun and Mr. Qi Anbang.

2